Security record · archived quarter
RDY
Dr. Reddy's Laboratories Limited · Healthcare · Drug Manufacturers - Specialty & Generic
9Tracked holders
—Δ holders
3.04MShares held
$231.32MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +2 | 105.67M | $1.53B | +6 | −4 |
| Q1 2026 | 82 | +2 | 99.82M | $1.38B | +9 | −7 |
| Q4 2025 | 79 | +1 | 89.69M | $1.26B | +1 | — |
| Q3 2025 | 15 | +1 | 51.12M | $714.60M | +1 | — |
| Q2 2025 | 11 | -3 | 34.60M | $520.04M | — | −3 |
| Q1 2025 | 11 | +2 | 23.21M | $306.17M | +2 | — |
| Q4 2024 | 9 | +1 | 22.23M | $350.98M | +1 | — |
| Q3 2024 | 7 | -2 | 2.98M | $236.56M | +1 | −3 |
| Q2 2024 | 9 | — | 3.04M | $231.32M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 2.00M | — | $152.04M | 0.3% | n/c | 1 | SEC ↗ |
| 2 | Millennium Management ✦ | 332.50K | — | $25.33M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fisher Asset Management ✦ | 308.16K | — | $23.48M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 174.62K | — | $13.30M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 91.19K | — | $6.93M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 73.80K | — | $5.62M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 46.55K | — | $3.55M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 7.68K | — | $585,215 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 6.33K | — | $482,587 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 245 holders, 116.00M shares, $1.54B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API